Literature DB >> 22395203

Wavy and elevated retinal pigment epithelial line in optical coherence tomographic images of eyes with atypical Vogt-Koyanagi-Harada disease.

Kei Shinoda1, Yutaka Imamura, Celso Soiti Matsumoto, Atsushi Mizota, Yasutaka Ando.   

Abstract

PURPOSE: We report the changes of the retinal pigment epithelium (RPE) determined by optical coherence tomography in a patient with atypical Vogt-Koyanagi-Harada (VKH) disease during the recovery phase.
METHOD: Case presentation.
RESULTS: A 74-year-old woman presented with a central scotoma associated with disc hyperemia, serous retinal detachment, and scleral thickening in her left eye, and was diagnosed with VKH. OCT showed a serous retinal detachment and a wavy RPE contour that corresponded to the choroidal folds. The OCT images clearly showed the dynamic changes of the retina, RPE, and choroid during the recovery phase.
CONCLUSIONS: The OCT was found to be more sensitive in detecting the choroidal folds than angiography. OCT images are valuable not only in the diagnosis, but also for monitoring the morphology of the retina and choroid during the course of VKH.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22395203     DOI: 10.1007/s00417-012-1977-9

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  7 in total

1.  Retinal cystoid spaces in acute Vogt-Koyanagi-Harada syndrome.

Authors:  Akitaka Tsujikawa; Kenji Yamashiro; Kaoruko Yamamoto; Atsushi Nonaka; Masashi Fujihara; Yasuo Kurimoto
Journal:  Am J Ophthalmol       Date:  2005-04       Impact factor: 5.258

2.  Optical coherence tomographic assessment of dynamic macular changes in patients with Vogt-Koyanagi-Harada disease.

Authors:  Junko Ikewaki; Kenichi Kimoto; Toshiharu Choshi; Mayuko Nagata; Yuka Motomura; Kouichirou Tamura; Kei Shinoda; Kazuo Nakatsuka
Journal:  Int Ophthalmol       Date:  2010-12-31       Impact factor: 2.031

3.  Choroidal folds in Vogt-Koyanagi-Harada disease.

Authors:  Weiju Wu; Feng Wen; Shizhou Huang; Guangwei Luo; Dezheng Wu
Journal:  Am J Ophthalmol       Date:  2006-12-28       Impact factor: 5.258

4.  Acute Vogt-Koyanagi-Harada disease in enhanced spectral-domain optical coherence tomography.

Authors:  Kenji Ishihara; Masanori Hangai; Mihori Kita; Nagahisa Yoshimura
Journal:  Ophthalmology       Date:  2009-07-30       Impact factor: 12.079

5.  Spectral-domain cirrus optical coherence tomography of choroidal striations seen in the acute stage of Vogt-Koyanagi-Harada disease.

Authors:  Vishali Gupta; Amod Gupta; Pawan Gupta; Aman Sharma
Journal:  Am J Ophthalmol       Date:  2008-10-02       Impact factor: 5.258

6.  Tomographic features of serous retinal detachment with multilobular dye pooling in acute Vogt-Koyanagi-Harada disease.

Authors:  Yumiko Yamaguchi; Tomohiro Otani; Shoji Kishi
Journal:  Am J Ophthalmol       Date:  2007-05-29       Impact factor: 5.258

7.  Frequency of distinguishing clinical features in Vogt-Koyanagi-Harada disease.

Authors:  Narsing A Rao; Amod Gupta; Laurie Dustin; Soon Phaik Chee; Annabelle A Okada; Moncef Khairallah; Bahram Bodaghi; Phuc Lehoang; Massimo Accorinti; Manabu Mochizuki; Tisha Prabriputaloong; Russell W Read
Journal:  Ophthalmology       Date:  2009-12-24       Impact factor: 12.079

  7 in total
  3 in total

1.  Analysis of choroidal folds in acute Vogt-Koyanagi-Harada disease using high-penetration optical coherence tomography.

Authors:  Kotaro Tsuboi; Kei Nakai; Chiharu Iwahashi; Fumi Gomi; Yasushi Ikuno; Kohji Nishida
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-02-10       Impact factor: 3.117

2.  Retinal pigment epithelium folds as a diagnostic finding of Vogt-Koyanagi-Harada disease.

Authors:  Yoshitake Kato; Yumiko Yamamoto; Hitoshi Tabuchi; Atsuki Fukushima
Journal:  Jpn J Ophthalmol       Date:  2012-11-14       Impact factor: 2.447

3.  Vogt-Koyanagi-Harada disease-like posterior uveitis in the course of nivolumab (anti-PD-1 antibody), interposed by vemurafenib (BRAF inhibitor), for metastatic cutaneous malignant melanoma.

Authors:  Toshihiko Matsuo; Osamu Yamasaki
Journal:  Clin Case Rep       Date:  2017-03-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.